{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:08:53Z","timestamp":1774120133737,"version":"3.50.1"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Clinical management of multisystem inflammatory syndrome in children (MIS-C) has varied over time and by medical institution.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Data on patients with MIS-C were collected from 4 children\u2019s hospitals between March 16, 2020 and March 10, 2021. Relationships between MIS-C treatments and patient demographics, clinical characteristics, and outcomes were described. Propensity score matching was utilized to assess the relative risk of outcomes dependent on early treatment with intravenous immunoglobulin (IVIG) or low-dose steroids, controlling for potential confounding variables.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Of 233 patients diagnosed with MIS-C, the most commonly administered treatments were steroids (88.4%), aspirin (81.1%), IVIG (77.7%) and anticoagulants (71.2%). Compared with those patients without respiratory features, patients with respiratory features were less likely to receive IVIG and steroids on the same day (combination treatment) (44.1%). Controlling for confounding variables, patients receiving IVIG within 1 day of hospitalization were less likely to have hospital length of stay \u22658 days (RR = 0.53, 95% CI: 0.31\u20130.88). Patients receiving low-dose steroids within 1 day of hospitalization were less likely to develop ventricular dysfunction (RR = 0.45, 95% CI: 0.26\u20130.77), have increasingly elevated troponin levels (RR = 0.55, 95% CI: 0.40\u20130.75) or have hospital length of stay \u22658 days (RR = 0.46, 95% CI: 0.29\u20130.74).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Treatments for MIS-C differed by hospital, patient characteristics and illness severity. When IVIG and low-dose steroids were administered in combination or low-dose steroids were administered alone within 1 day of hospitalization, the risk of subsequent severe outcomes was decreased.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004065","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T22:04:40Z","timestamp":1697839480000},"page":"990-998","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Treatments and Severe Outcomes for Patients Diagnosed With MIS-C at Four Children\u2019s Hospitals in the United States, March 16, 2020\u2013March 10, 2021"],"prefix":"10.1097","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3579-8609","authenticated-orcid":false,"given":"Ami B.","family":"Shah","sequence":"first","affiliation":[{"name":"CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"},{"name":"General Dynamics Information Technology, Falls Church, Virginia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph Y.","family":"Abrams","sequence":"additional","affiliation":[{"name":"CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shana","family":"Godfred-Cato","sequence":"additional","affiliation":[{"name":"CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber","family":"Kunkel","sequence":"additional","affiliation":[{"name":"CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"},{"name":"Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa A.","family":"Hammett","sequence":"additional","affiliation":[{"name":"CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria A.","family":"Perez","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia and Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Mien","family":"Hsiao","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia and Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Baida","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia and Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina A.","family":"Rostad","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia and Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wassim","family":"Ballan","sequence":"additional","affiliation":[{"name":"Phoenix Children\u2019s Hospital, Phoenix, Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaleo","family":"Ede","sequence":"additional","affiliation":[{"name":"Phoenix Children\u2019s Hospital, Phoenix, Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico R.","family":"Laham","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Diseases, Orlando Health Arnold Palmer Hospital for Children, Orlando, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol M.","family":"Kao","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew E.","family":"Oster","sequence":"additional","affiliation":[{"name":"CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"},{"name":"Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia and Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ermias D.","family":"Belay","sequence":"additional","affiliation":[{"name":"CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,10,11]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(20)31094-1","article-title":"Hyperinflammatory shock in children during COVID-19 pandemic.","volume":"395","author":"Riphagen","year":"2020","journal-title":"Lancet"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.15585\/mmwr.mm6940e1","article-title":"Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection - United Kingdom and United States, March-August 2020.","volume":"69","author":"Morris","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1002\/art.41616","article-title":"American College of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and Hyperinflammation in pediatric COVID-19: Version 2.","volume":"73","author":"Henderson","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association.","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1710-1492-9-30","article-title":"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy.","volume":"9","author":"Liu","year":"2013","journal-title":"Allergy Asthma Clin Immunol"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v042.i08","article-title":"MatchIt: nonparametric preprocessing for parametric causal inference.","volume":"42","author":"Ho","year":"2011","journal-title":"J Stat Softw"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S2352-4642(21)00050-X","article-title":"Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study.","volume":"5","author":"Abrams","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.15585\/mmwr.mm6932e2","article-title":"COVID-19-Associated multisystem inflammatory syndrome in children - United States, March-July 2020.","volume":"69","author":"Godfred-Cato","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40746-021-00224-9","article-title":"Management of multisystem inflammatory syndrome in children associated with COVID-19 infection.","volume":"7","author":"Jone","year":"2021","journal-title":"Curr Treat Options Peds"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa2102605","article-title":"Multisystem inflammatory syndrome in children - initial therapy and outcomes.","volume":"385","author":"Son","year":"2021","journal-title":"N Engl J Med"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa2102968","article-title":"Treatment of multisystem inflammatory syndrome in children.","volume":"385","author":"McArdle","year":"2021","journal-title":"N Engl J Med"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1161\/CIRCULATIONAHA.120.050147","article-title":"Addition of corticosteroids to immunoglobulins is associated with recovery of cardiac function in multi-inflammatory syndrome in children.","volume":"142","author":"Belhadjer","year":"2020","journal-title":"Circulation"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s00431-022-04390-2","article-title":"COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group.","volume":"181","author":"Yilmaz Ciftdogan","year":"2022","journal-title":"Eur J Pediatr"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jemermed.2020.09.008","article-title":"Multisystem Inflammatory Syndrome in Children (MIS-C) in an adolescent that developed coronary aneurysms: a case report and review of the literature.","volume":"59","author":"Nelson","year":"2020","journal-title":"J Emerg Med"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s12519-021-00435-y","article-title":"Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.","volume":"17","author":"Zhang","year":"2021","journal-title":"World J Pediatr"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/pai.13645","article-title":"Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): distinct from Kawasaki disease or part of the same spectrum?","volume":"33","author":"Santaniello","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"key":"R19-20250614","first-page":"1141","article-title":"Kawasaki disease: summary of the American Heart Association guidelines.","volume":"74","author":"Freeman","year":"2006","journal-title":"Am Fam Physician"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijcard.2017.01.068","article-title":"Factors associated with development of coronary artery aneurysms after Kawasaki disease are similar for those treated promptly and those with delayed or no treatment.","volume":"236","author":"Downie","year":"2017","journal-title":"Int J Cardiol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004065","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:03:57Z","timestamp":1749945837000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,11]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004065","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,11]]}}}